02.06.2013 Views

Health Risks of Ionizing Radiation: - Clark University

Health Risks of Ionizing Radiation: - Clark University

Health Risks of Ionizing Radiation: - Clark University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

myeloid leukemia) was significantly associated<br />

with dose as was mortality from multiple<br />

myeloma 9 . Wilkinson and Dreyer (1991) pooled<br />

the leukemia mortality results <strong>of</strong> seven worker<br />

studies. These authors found a significant risk<br />

among workers with doses <strong>of</strong> 0.01-0.05 Sv<br />

(Rate ratio 2.1, 90% CI 1.4-3.3).<br />

• Leukemia among nuclear weapons test<br />

veterans. Veterans who were involved with<br />

nuclear weapons testing were typically exposed<br />

to low doses <strong>of</strong> radiation 10 . Muirhead et al. (2003)<br />

did not detect any significant dose-response<br />

trends in a subgroup <strong>of</strong> UK veterans with dose<br />

information, but this is not surprising given the<br />

low numbers <strong>of</strong> cases 11 . UK veterans followed<br />

through 1983 showed increased mortality from<br />

leukemia (RR 3.45, 90% CI 1.50-8.37) and<br />

multiple myeloma (6 deaths among participants<br />

and zero deaths among controls); total cancer<br />

mortality was not different from controls (RR<br />

0.96, 90% CI 0.86-1.08). A purely low-dose<br />

cohort was studied by Caldwell et al. (1983);<br />

these were veterans <strong>of</strong> one test (Smoky, 1957)<br />

who had a mean dose <strong>of</strong> 0.005 Sv and a maximum<br />

dose <strong>of</strong> 0.1 Sv. Among these veterans there was<br />

a significant excess <strong>of</strong> leukemia, registered as<br />

either incidence or mortality (incidence RR<br />

2.5, 1.2-4.6), and total cancer mortality was not<br />

different from expected (incidence RR 0.95,<br />

0.78-1.14).<br />

• Medical exposures and leukemia. Studies <strong>of</strong><br />

diagnostic x-rays are <strong>of</strong> limited utility because<br />

they typically lack dose estimates. In one study<br />

that did estimate doses there was evidence <strong>of</strong><br />

a chronic myeloid leukemia risk at low doses<br />

(Preston-Martin et al. 1989). Out <strong>of</strong> 130 cases<br />

and 130 matched controls 80% had estimated<br />

cumulative bone marrow doses less than 0.02<br />

Gy. The maximum dose in this group would have<br />

Discussion 169<br />

been received by one patient who had 22 back<br />

x-rays; at 247-749 mrad per exam this would be<br />

a cumulative dose <strong>of</strong> 0.05-0.16 Gy. This group<br />

showed a significant dose-response relationship<br />

with an estimated ERR <strong>of</strong> 30/Gy. When analysis<br />

was restricted to the period within 6-10 years <strong>of</strong><br />

diagnosis the ERR estimate was 76/Gy and the<br />

OR for the 0.01-0.02 Gy exposure group was<br />

significantly positive (3.1, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!